chrisvoncsefalvay/vaers-outcomes huggingface dataset:
In less that 24 hours I had 4 bouts of diarrhea, mild fever, and site soreness.  After 24 hours I started experiencing ?brain fog? or mental confusion, unable to pull common words while trying to speak.  Some visual hallucinations, and extreme leg muscle/joint pains, as I had experienced during my critical adverse reaction to antibiotics in 2015.  Almost 3 weeks out from dose 1 of vaccine, 2 days away from receiving 2nd dose and am still experiencing brain fog, hallucinations, and muscle/joint pains.
Severe immune response, arm pit swelling, lymph glams swelling, intense muscle pain, fever, shoulder pain, muscle spasms, weakness, and brain fog.
Pt called that same day after getting the Men B #1 while at home @ 5:36PM started to feeling tingling sensation all over her body nausea light headed as if she was going to pass out. On call MD called back at 6PM advised if not better in 2o mins go to the closest ER but I started feeling a little better around 6pm so I stayed home. She felt better the next day just have some pain tender at the injection site.
Patient is here today for his covid vaccination. It was noted  that he was unconscious.   At 11:00, monitored by EMS for 15 minutes.    History of:NA   Nursing Assessment:  Airway: Open Breathing: Spontaneous Circulation: Pulse present Mentation: Alert Skin: Normal    Patient fainted after receiving Pfizer vaccine and was lowered to the floor, feet were raised, cold towels were applied to the patient's face, and patient was monitored on site by EMS with no further incidence and released to home care with his parent at 11:20.
Patient administered the adult bilvalent booster of 0.3ml dose instead of the recommended dose.
Initial report received via search of the literature on 16 April 2013. This case contains information for 1 of 22 patients whose clinical data were provided. Information regarding the other 21 patients is captured in case numbers: 2013-05188, 2013-005252 to 2013-005263, 2013-05268, 2013-05269, 2011-03827, 2006-03086, 1995-00668, 2006-03230, 1995-00224 and 2003-02926. From the published article, the authors reviewed charts of patients who had been hospitalized with Guillain-Barre Syndrome (GBS) from 1995 through 2006. Using a case-centered design, they compared the odds of vaccination in the 6 and 10 weeks prior to onset of GBS to the odds of vaccination during the same time intervals in all vaccinated individuals in the entire hospital population. While cases of GBS had been reported following a wide range of vaccines, a clear association had only been established with the 1976 H1N1 inactivated influenza vaccine. The authors confirmed 415 cases of which only 25 had received any vaccine in the six weeks prior to GBS onset. Vaccines received included TIV, 23-valent polysaccharide pneumococcal vaccine, tetanus-diphtheria combination vaccines, Hepatitis A and Hepatitis B. The large retrospective study did not find any association between influenza vaccine or any other vaccine and the development of GBS within 6 weeks following vaccination. According to the authors, the risk of GBS following any vaccine, including influenza vaccines, was extremely low. Regarding this case which involved a 65-year-old female patient who had received Trivalent inactivated influenza vaccine (manufacturer unknown; lot number, route, site and date of administration not reported) and three days later reported the onset of GBS. No further information was provided. Outcomes were not reported. Documents held by sender: none.
Side effects 2 to 3 hours after receiving shot.  Headache, body aches, fever, tiredness/fatique.  Most passed the next day about 24 hours expect tiredness and fatique and body aches.  July 6th started coughing with shortness of breath with bloating of stomach.  Went to Dr. on July 12th diagnosed with upper respiratory infection and wheezing.  Prescribed antiboitic and inhaler.  July 19th went to Urgent Care Dr. could not see me.  Face drooping numbness left side of face ear hurting eyes watering diagnosed with Bells Palsy.  Given steriod and anti viral.  Still had shortness of breath and coughing went back to Dr. July 26th.  Said lung sounded better. to continue treatment with inhaler.
Fever spike to 102, muscle pain at injection site and all over left side of the body. The fever started at night on 1/21/21 and spiked over 100 around 7am the next day (1/22/21). The fever broke around 5 pm on 1/22/21 after taking Tylenol (2 tablets every 6 hours started around 9am on 1/22). My temperature dropped to 98.9 around 5pm on 1/22; Continued drinking fluids and took another dose of Tylenol before bed at 12:30am. Woke up with no fever the next day (1/23) however muscle pain on the left side of the body is still present.
Varicella vaccine given in left arm and Hep A given in left deltoid IM on 6/15/09. Presented 5 days later with itchy bumps/ vesicles starting on arms, then legs. Most scabbing in different days of healing. Physician who saw child at that time diagnosed varicella secondary to the recent vaccination.
**IMPROPER/WRONG ELIGIBILITY USED FOR BOOSTER SHOT**  THE PATIENT WAS GIVEN VACCINATION ON 10/27/21 ON AN OUTSIDE CLINIC. AFTER PATIENT SUBMITTED THE FORM, THE SUPERVISOR OF THE VACCINATION CLINIC FOUND OUT THE PATIENT HAS HER SECOND SHOT ON 5/26/21, WHICH WAS LESS THAN 6 MONTH AGO. THE FORM WAS REMOVED FROM THE FILE, BUT WHEN I AND NURSES WENT TO THE UPSTAIRS TO GIVE PATIENTS SHOTS, I RUSHED AND GAVE THE PATIENT VACCINATION WHICH THE NURSE POINTED (WHO WAS USING THE OLD LIST). AFTER GIVING THE SHOT, I REALIZED THE RX HAD BEEN REMOVED FROM THE FILE BECAUSE OF THE ELIGIBILITY ISSUE.
2 weeks after I got my 2nd shot, I got a pea sized lump on the tendon in the middle of my hand that gave me trigger finger and it was very sore. It lasted for about a month. I had to get a steroid injection into the middle of my hand and that made is gradually go away.
This spontaneous report was received from a medical assistant, referring to a 16 year old patient of unknown gender. The patient had no pertinent medical history, concurrent conditions, drug reactions/allergies, or concomitant medications. On 31-JUL-2018, the patient was vaccinated with GARDASIL 9 lot # N025429 (expiration date: 21-JUL-2020) for prophylaxis (strength, dose, frequency, route of administration were not reported). Subsequently, about two after the administration, of hpv GARDASIL 9, the patient became "unresponsive, shortness of breath and looked pale in the color" (unresponsive to stimuli, dyspnea, and pallor, respectively). Subsequently, the emergency medical service was called and the patient was taken to an unspecified hospital emergency room. No laboratory diagnostic studies were performed. By the time of the report, the outcome of unresponsive to stimuli, dyspnoea and pallor was unknown. The causality relationship between the aforementioned events and GARDASIL 9 was not reported. Upon internal review, unresponsive event was determined, to be medically significant. All telephone attempts to obtain follow up information have been unsuccessful and additional information has been requested. This is one of several reports received from the same reporter.; Sender's Comments: US-1009507513-1808USA000591: US-1009507513-1808USA000589:
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (soreness in arm) and product dose omission issue (didn't get her 2nd shot) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot 027A21A) for COVID-19 vaccination. Concomitant products included furosemide for an unknown indication. On Mar 19, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), unknown route; 1 dosage form. On Mar 19, 2021, patient experienced pain in extremity (soreness in arm) and product dose omission issue (didn't get her 2nd shot). On Mar 19, 2021, product dose omission issue (didn't get her 2nd shot) resolved. On Mar 23, 2021, pain in extremity (soreness in arm) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Other concomitant medications included blood thinner and inactive thyroid medicines. No treatment medication reported.
About a month after getting the last shot of the Pfizer vaccine had a bad seizure(tonic-clonic). Was put on keppra by a neurologist then 2.5 months later had another episode (status epilepticus) lasted about 7 minutes all together, in both occasions 911 was called but wasn't take to the hospital. I was diagnosed with epilepsy at 13 years old. Was taking medication until I was 21, but started taking it again because of these recent events. July 19/2021 the first time I had a seizure. When last time I had one I was about 18 years old. I was seizure free for about 10 years. Been that the vaccine is the only different thing done out of the normal. It lead us to believe that the vaccine was the trigger to my seizure to come back.
SKIN RASH, ITCHING BLISTER. FEVER BRAIN FOG- PT CAN NOT REMEMBER DAY AND TIME
Body aches; fingers were hurting from cold; fingers were hurting from cold; can't call them chills, but her body temperature got really low; feels too weak; broke into a fever and got to 101.4 F; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FATIGUE (feels too weak), PERIPHERAL COLDNESS (fingers were hurting from cold), PAIN IN EXTREMITY (fingers were hurting from cold), PYREXIA (broke into a fever and got to 101.4 F) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low). On 22-Jan-2021 at 9:15 AM, the patient experienced MYALGIA (Body aches). On 22-Jan-2021, MYALGIA (Body aches), PERIPHERAL COLDNESS (fingers were hurting from cold) and PYREXIA (broke into a fever and got to 101.4 F) had resolved, PAIN IN EXTREMITY (fingers were hurting from cold) outcome was unknown. At the time of the report, FATIGUE (feels too weak) and BODY TEMPERATURE DECREASED (can't call them chills, but her body temperature got really low) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101.4 (High) 101.4 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported. 15 minutes later to the vaccination, at 7.32, the patient left the clinic and was still good, until 9.15 the day of report, when she got body aches. At 9.40 she experienced "can't call them chills, but her body temperature got really low", her fingers were hurting from cold. At 10.30 she broke into a fever and got to 101.4°F.
This medically confirmed spontaneous report (initial receipt: 13-Oct-2011) concerns a 51 year old male patient, who had no pre-existing allergies, birth defects or medical conditions. On 04-Oct-2011 the patient received an unidentified "flu vaccine" into the right arm. On the same day at 14:21 the patient also received 0.5 mL of PNEUMOVAX 23 injection (lot number 0614AA) intramuscularly into left arm deltoid for vaccination. On 05-Oct-2011, after vaccination, the patient developed an infection in the left arm, a 99.4 degree F (Fahrenheit) fever, and decreased range of motion. The patient's left arm was hot, red and swollen from the deltoid to the elbow ("all the way") when seen by a doctor on 06-Oct-2011. Redness was noted on the left upper chest wall. The deltoid down to his elbow was painful. The patient was diagnosed with cellulitis and prescribed doxycycline 100 mg twice daily for 7 days. On a follow up call to the patient, the arm had improved. It was reported that the patient had no reaction to the unidentified "flu vaccine" that was administered to the right arm. The event outcome was recovered. The reporter stated that the dose of PNEUMOVAX 23 given was one of the two final doses from the multi dose vial. Follow-up (18-Nov-2011): additional AE term, PNEUMOVAX 23 vaccination time, event summary description, AE onset date, no pre-existing allergies, birth defects or medical conditions.
soreness in the arm around 2 hours after vaccine given, continued soreness in the upper shoulder for the 7  days. Occasionally has trouble lifting arm to the side and above shoulder/head.
About 6 hours after receiving vaccine, I developed severe fatigue, dizziness, nausea and myalgias. I concurrently experienced a low-grade fever and tachycardia. In addition, I had severe pain at the injection in my right deltoid that significantly limited my ability to lift my arm. The pain extended all the way from my shoulder through my right wrist. Most symptoms, except for fatigue and pain limited to the injection site, resolved after 24 hours.
Syncope. At age 13, I was walking out of the doctor's office after receiving an MMR shot and Tdap shot simultaneously. I became dizzy and then yellow spots appeared in my field of vision and then I fainted. The nurse caught me and sat me in a chair. She had me place my head between my legs. I felt fine after about 20 minutes.  My (biological) mother also recalls fainting when she received her Polio vaccine as a child.
Pts face became covered in hives on right cheek within 10 min. Pt was observed for another 10 min and was okay. Pt was released.
This study case was received from the investigator on 08 August 2012. A female subject (date of birth not reported) with a past medical history of an intermittent dry cough was found to have on 01 August 2012 an elevated Troponin level of 0.16 ng/ml nine days after the subject had received on 23 July 2012 the following vaccines: ACAM2000 (lot number, route and site of administration not reported), an injection of TYPHOID VACCINE (lot number, route and site of administered not reported) and ANTHRAX VACCINE (manufacturer, lot number, route and site of administration not reported). On 30 July 2012, the subject's smallpox injection site was reported to look "big, pus like and big". The subject reports mild burning left arm injection site. On 28 July 2012, the subject had moderate itching of left arm injection site. "No other adverse events (AE's) reported. No cardiac AE's, no chest pain, no HURT marked on Wong Baker scale." Laboratory tests (Labs) were drawn and a "rapid test" was negative. On 02 August 2012, the subject reported for an unscheduled visit and had an EKG which was normal with sinus bradycardia and repeat Troponin level was "down to normal at < 0.10 ng/ml (date of drawn also reported as 30 July 2012). The subject also reported an intermittent dry cough that started on 30 July 2012. According to the investigator, the dry cough was "likely unrelated" and no further treatment or workup was needed. Concomitant medications were reported as none. No further information was available at the time of the report. The subject's outcome was recovered on 03 August 2012. This represents a case of potential myopericarditis per the Investigator and has subsequently been referred to the ACAM2000 Myopericarditis Adjudication Committee for assessment. Documents held by sender: medical records.
Pt was supposed to get the last Rabies vaccine in her series (day 14) on 9/9/22 but got it on day 11 (9/5/22).
pt recv vax 26MAY93 (date is approximate) & exp numbness & tenderness in the inj arm;
1st day after the shot - I had a strong reaction to the 2nd dose of the Pfizer vaccine - usual symptoms, muscle aches, headache. 2nd day after the shot - mild achiness, getting better. 3rd day after the shot - significant chest pains in the left chest.  Went to hospital.  Blood test showed elevated levels of troponin.  I was admitted, stayed overnight, and the next day underwent an angiogram (no blockages), a sonogram (no markers for pulmonary embolism). My last test was a cardiac MRI which definitively showed that I had MYOCARDITIS.  Symptoms subsided and I was discharged from the hospital that same day on April 2nd.  I've since resumed my normal workout regimen with no lasting symptoms, only a large hospital bill.
Patient fainted then began to seize 19 minutes after injection was given. Patient was then transported by EMS to nearest ED.
Numbness and tingling in left arm for a few hours, eventually went away Swollen lymph node under left armpit, still swollen today
Intermittent Chest Pain, Palpitations, burning sensation in the area of the heart, weakness, hyperventilation due to pain, inability to sleep, and chronic cough while standing or sitting but not while laying prone. Seen at Atrium Health Urgent Care Clinic Shelby NC on 14 Mar 2021. Then at the Emergency Room CaroMont Regional Medical Center Gastonia NC on 17 Mar 2021. Seen by PA-C on 19 Mar 2021 at Novant Health Family Physicians of Gastonia. Then seen again at the Emergency Room CaroMont Regional Medical Center Gastonia NC on 20 Mar 2021. Symptoms have begun to subside as of the date 28 Mar 2021 with the exception of the chronic cough.
Felt like she had a temperature; Disoriented; Could not concentrate; ringing in ears; Not sure it was injected in the muscle / up towards her shoulder; Around the injection site was pain; Around the injection site / redness; Around the injection site / swelling; Dizzy; no appetite; had to get up at night to put water on face; headache; shivering; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 2nd November 2020, the patient received the 2nd dose of Shingrix. On 2nd November 2020, less than a day after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced injection site pain, injection site erythema, injection site swelling, dizziness, appetite absent, insomnia, headache, shivering and vaccine administered at inappropriate site. On 3rd November 2020, the patient experienced disorientation, concentration impaired and ringing in ears. On an unknown date, the patient experienced feeling of warmth. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain, injection site erythema, injection site swelling, appetite absent, insomnia, shivering, feeling of warmth, disorientation, concentration impaired, ringing in ears and vaccine administered at inappropriate site were unknown and the outcome of the dizziness and headache were not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site swelling, dizziness, appetite absent, insomnia, headache, shivering, feeling of warmth, disorientation, concentration impaired and ringing in ears to be related to Shingrix.  Additional details were provided as follows: The patient was not sure if the 2nd dose of Shingrix was injected in the muscle of her left arm; it was up towards her shoulder.  After receiving Shingrix, the patient experienced pain, redness and swelling around the injection site. 2.5 hours after 2nd dose of Shingrix, the patient was dizzy so bad that she was forced to lay down.  The patient had no appetite and had to get up and put water on her face.  She also had a headache, shivering and felt like she had a temperature.   The patient called her pharmacist in the morning and was disoriented and could not concentrate.  On 03rd November 2020, she still had dizziness and now ringing in ears and headache. Dizziness was less but overall, she had a horrible experience. The reporter did not consent to follow-up. For the tolerance of 1st dose, refer linked case US2020AMR222031.; Sender's Comments:  US2020AMR222031:1st dose US-GLAXOSMITHKLINE-US2020AMR222031:for 2nd dose
Pt. states that after receiving the 1st dose of DTap 08/03/2021. 08/04/2021 started experiencing Migraines, underarm pain, continuing to feel fatigue with loose stool, full body aches, Fever (100.1), chills, 08/06/2021 feels like pins and needles, stomach ache, loose stool continue. Primary visit scheduled for 08/09/2021.
Temperature of 100.6 today (day after 2nd injection).  To be expected.
Information has been received from a registered nurse concerning a 6 year old male with no medical history or allergies who on 08-MAY-2002 was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (Lot # 635455/1145K). There was no concomitant medication. On 27-NOV-2007, the patient developed a mild chickenpox rash. No treatment was needed. No diagnostic laboratory tests were undertaken. At the time of report the patient was recovering. A product quality complaint was not involved. Additional information has been requested. This is on of several reports received from the same source.
Patient had small amount of bleeding at time of injection but noticed 2 days later that he had a large bruise/subdermal bleeding that appeared to start at the injection site and migrate down the arm to the inner elbow on the left arm. He takes warfarin and showed it to the clinic nurse who stated that it would be ok and just get reabsorbed. He had mild soreness at the injection site on the evening of 9/17/2020 but no pain or discomfort otherwise.
Heart stopped (15Feb2021) day after second shot; coma; This is a spontaneous report from a contactable consumer (patient).   An 85-year-old female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration (at the age of 85-years-old), administered in Arm Right on 14Feb2021 12:00 (Lot Number: E9262) as single dose for COVID-19 immunisation. Medical history included Distal dystrophy, allergies to Sulfur. The patient was not pregnant. The patient was not diagnosed with COVID prior vaccination. Concomitant medication included citalopram, levothyroxine, vitamin D3; all taken for unspecified indications, start and stop dates were not reported. The patient previously took Plaquenil [hydroxychloroquine phosphate] and experienced allergies. The patient previously received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration (at the age of 85-years-old), administered in Arm Right on an unspecified date (Lot Number: E9269) as single dose for COVID-19 immunisation. The patient's heart stopped (15Feb2021, 04:00 PM) on the day after second shot. In ICU, induced into coma, hospitalized 6 weeks. No history of heart problems, "had EKG several weeks before 1st shot\ -v was normal." Still under doctors' care. The patient underwent lab tests and procedures which included electrocardiogram: normal on an unspecified date. The events resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event). The patient was hospitalized for the events for 42 days. Therapeutic measures were taken as a result of the events which included "Coded 2x, Incubated, induced coma, pacemaker." The outcome of the events was recovering. No other vaccine in four weeks. The patient was not tested for COVID post vaccination.